http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2014148964-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5073 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5084 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1635 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1611 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1623 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1617 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-427 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-426 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5089 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2072 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 |
| filingDate | 2013-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2014148964-A |
| titleOfInvention | Antiretroviral Composition |
| abstract | 1. A solid pharmaceutical composition for oral administration in a sprinkler form containing a plurality of particles, wherein said plurality of particles comprises first and second antiretroviral drugs and at least one polymer, wherein the first antiretroviral drug is ritonavir. The solid pharmaceutical composition for oral administration in the sprinkler form according to claim 1, wherein ritonavir is present in the form of a pharmaceutically acceptable salt, a pharmaceutically acceptable solvate, a pharmaceutically acceptable ester, a pharmaceutically acceptable enantiomer, a pharmaceutically acceptable derivative, a pharmaceutically acceptable polymorph, a pharmaceutically acceptable prodrug or pharmaceutically acceptable complex. 3. A solid pharmaceutical composition for oral administration in the sprinkler form according to claim 1, wherein ritonavir is present in the form of a pharmaceutically acceptable solvate thereof. A solid pharmaceutical composition for oral administration in the sprinkler form according to claim 1, wherein ritonavir is present in the form of its ethanolate solvate, formamide solvate or partially desolvated formamide solvate. A solid pharmaceutical composition for oral administration in a sprinkler form according to claim 1, wherein the second antiretroviral drug is a protease inhibitor; nucleoside reverse transcriptase inhibitor; nucleotide reverse transcriptase inhibitor; non-nucleotide reverse transcriptase inhibitor; integrase inhibitor; maturation inhibitor or any and |
| priorityDate | 2012-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 116.